Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qinghai Mingyuewang Biotechnology is a health-focused biotechnology company headquartered in Xining, China, specializing in the utilization of plateau-specific biological resources. The company primarily focuses on the research, development, and large-scale production of sea buckthorn (Hippophae rhamnoides) and wolfberry-based products. Its portfolio includes high-purity sea buckthorn oils, softgel capsules, and functional health foods designed for nutritional support and antioxidant benefits. By leveraging the unique ecological environment of the Qinghai-Tibet Plateau, the company provides raw materials and finished health products to both domestic and international markets. The company operates manufacturing facilities that adhere to health food production standards to ensure product quality and efficacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qinghai Mingyuewang Biotechnology.